Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2012, Article ID 369820, 5 pages
http://dx.doi.org/10.1155/2012/369820
Clinical Study

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence

Department of Radiology, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-ku, Sapporo 060-8638, Japan

Received 25 April 2012; Accepted 23 May 2012

Academic Editor: Yuzuru Niibe

Copyright © 2012 Tetsuya Inoue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Hellman and R. R. Weichselbaum, “Oligometastases,” Journal of Clinical Oncology, vol. 13, no. 1, pp. 8–10, 1995. View at Google Scholar · View at Scopus
  2. Y. Niibe, T. Kazumoto, T. Toita et al., “Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study,” Gynecologic Oncology, vol. 103, no. 2, pp. 435–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Niibe, M. Kenjo, T. Kazumoto et al., “Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 5, pp. 1366–1369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Niibe, M. Kuranami, K. Matsunaga et al., “Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence,” Anticancer Research, vol. 28, no. 6 B, pp. 3929–3931, 2008. View at Google Scholar · View at Scopus
  5. J. K. Salama, S. J. Chmura, N. Mehta et al., “An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease,” Clinical Cancer Research, vol. 14, no. 16, pp. 5255–5259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. T. Milano, A. W. Katz, A. G. Muhs et al., “A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions,” Cancer, vol. 112, no. 3, pp. 650–658, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. W. Flannery, M. Suntharalingam, W. F. Regine et al., “Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 1, pp. 19–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. T. Milano, H. Zhang, S. K. Metcalfe, A. G. Muhs, and P. Okunieff, “Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy,” Breast Cancer Research and Treatment, vol. 115, no. 3, pp. 601–608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Khan, P. S. Mehta, T. W. Zusag et al., “Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC),” Radiotherapy and Oncology, vol. 81, no. 2, pp. 163–167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Onishi, H. Shirato, Y. Nagata et al., “Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study,” Journal of Thoracic Oncology, vol. 2, supplement 7, pp. S94–S100, 2007. View at Google Scholar · View at Scopus
  11. P. Baumann, J. Nyman, M. Hoyer et al., “Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy,” Journal of Clinical Oncology, vol. 27, no. 20, pp. 3290–3296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Shirato, S. Shimizu, T. Kunieda et al., “Physical aspects of a real-time tumor-tracking system for gated radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 48, no. 4, pp. 1187–1195, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Shirato, S. Shimizu, K. Kitamura et al., “Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor,” International Journal of Radiation Oncology Biology Physics, vol. 48, no. 2, pp. 435–442, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Norihisa, Y. Nagata, K. Takayama et al., “Stereotactic body radiotherapy for oligometastatic lung tumors,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 2, pp. 398–403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. K. E. Rusthoven, B. D. Kavanagh, S. H. Burri et al., “Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases,” Journal of Clinical Oncology, vol. 27, no. 10, pp. 1579–1584, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. The International Registry of Lung Metastases, “Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases,” Journal of Thoracic and Cardiovascular Surgery, vol. 113, no. 1, pp. 37–49, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Inoue, N. Katoh, H. Aoyama et al., “Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions,” Japanese Journal of Clinical Oncology, vol. 40, no. 8, pp. 788–794, 2010. View at Publisher · View at Google Scholar · View at Scopus